Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Analyst Ratings
Bernstein Reiterates Sell Rating on Ormat Technologies
Analyst Sunaina Ocalan sets a $115 target for Ormat Technologies.
Analyst Ratings
BTIG Reiterates Buy Rating on Evolus, Inc. (EOLS)
BTIG maintains its buy stance on Evolus with a $13 price target.
Analyst Ratings
HC Wainwright Reaffirms Buy Rating on Hemab Therapeutics
HC Wainwright maintains its buy rating on Hemab Therapeutics with a $40 price target.
Analyst Ratings
HC Wainwright Reiterates Buy Rating on Silence Therapeutics
HC Wainwright maintains a buy rating on Silence Therapeutics, setting a $75 price target.
Analyst Ratings
Needham Reiterates Buy Rating for The Oncology Institute, Inc. (TOI)
Needham maintains its buy rating for The Oncology Institute, Inc. with a $7 price target.
Analyst Ratings
HC Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals
HC Wainwright maintains its buy rating on Phathom Pharmaceuticals with a $26 target.
Analyst Ratings
BTIG Upgrades TPG Mortgage Investment Trust to Buy
BTIG analyst Douglas Harter upgrades TPG Mortgage Investment Trust to Buy with a $9 price target.
Analyst Ratings
BTIG Reiterates Buy Rating on Angel Oak Mortgage REIT
BTIG continues to recommend Angel Oak Mortgage REIT with a $10 price target.
Analyst Ratings
BTIG Upgrades MFA Financial, Inc. to 'Buy' with New Price Target
BTIG analyst Douglas Harter raised MFA Financial's rating to 'buy' with a $10.5 price target.
Analyst Ratings
BTIG Reiterates Buy Rating for Redwood Trust, Inc.
BTIG maintains a buy rating on Redwood Trust, Inc. with a $6 price target.
Analyst Ratings
BTIG Reiterates Buy Rating for Velocity Financial
BTIG analyst Douglas Harter maintains a buy rating on Velocity Financial, Inc. with a $22 price target.
Analyst Ratings
Baird Reiterates Buy Rating for Schneider National, Inc.
Baird has reiterated its buy rating on Schneider National with a $39 price target.
Analyst Ratings
B of A Securities Downgrades Leidos Holdings to 'Hold'
Leidos Holdings receives a downgrade from B of A Securities with a new price target.
Analyst Ratings
B of A Securities Reiterates Buy on Guardian Pharmacy Services, Inc.
B of A Securities maintained its buy rating for Guardian Pharmacy Services with a $47 price target.
Analyst Ratings
HC Wainwright Reiterates Buy Rating on Opus Genetics
Opus Genetics receives a buy rating reiteration from HC Wainwright with an $8.00 target.
Analyst Ratings
Goldman Sachs Downgrades Ermenegildo Zegna to Hold
Goldman Sachs analyst Adrien Duverger downgrades Zegna to hold with a $14 target.
Analyst Ratings
Canaccord Genuity Reiterates Buy Rating on Central Garden & Pet
Canaccord Genuity maintains its buy rating for Central Garden & Pet with a $53 price target.
Analyst Ratings
Benchmark Reiterates Buy Rating on Cinemark Holdings
Benchmark maintains its buy rating for Cinemark Holdings, setting a $37 target price.
Analyst Ratings
Citizens Reiterates Buy Rating on Encore Capital Group, Inc.
Encore Capital Group, Inc. receives a buy rating from Citizens with a $115 price target.
Analyst Ratings
Citizens Reiterates Buy Rating for Sphere Entertainment Co.
Citizens has reaffirmed its buy rating on Sphere Entertainment Co. with a $200 price target.
Analyst Ratings
Truist Securities Reiterates Buy Rating on Guardian Pharmacy Services
Truist Securities maintains its Buy rating on Guardian Pharmacy Services with a $47 price target.
Analyst Ratings
Truist Securities Reiterates Buy Rating on Lineage, Inc.
Truist Securities maintains its buy stance on Lineage, Inc., setting a $46 price target.
Analyst Ratings
DA Davidson Reiterates Buy Rating on Open Lending
DA Davidson maintains its 'buy' rating for Open Lending with a $3.00 target.
Analyst Ratings
Mizuho Upgrades Huntsman Corporation to Hold
Mizuho raised its rating on Huntsman Corporation to hold, setting a $14 price target.